Stage 5: regulator-cleared.
The rule that placed itA regulator has cleared or approved it for the task, where approval applies (for example the FDA for medical AI). Tasks no regulator covers are marked “No approval process exists”.
The evidenceCalifornia's utilities regulator approved Waymo's driverless service for more of the San Francisco Bay Area. California Public Utilities Commission, May 19, 2025.
A stage says how far the evidence has got. It is not a rating of the AI and not advice.
- 1ClaimedEvidence found
- 2LaunchedNo evidence yet
- 3Independently testedNo evidence yet
- 4Tested with real peopleNo evidence yet
- 5Regulator-clearedPlaced here
- 6Widely used with a verified recordNo evidence yet
Everything we found.
In ladder order, newest first within each kind. Makers' own claims are labeled as theirs.
What the makers claim
- Waymo (company-reported)
“Compared to humans, Waymo has 95% fewer serious injury-or-worse crashes,”
The Atlanta Journal-Constitution · Oct 11, 2026 · company-reported
- Waymo (company-reported)
“the Waymo Driver has a large, statistically significant, reduction in crash rates compared to the human benchmark”
Waymo Safety Impact hub (data through June 2026) · Jun 2026 · company-reported
Rules and approvals
- US · Approval · California Public Utilities Commission
California's utilities regulator approved Waymo's driverless service for more of the San Francisco Bay Area.
“Therefore, CPED approves Waymo's updated PSP and authorizes expansion of Waymo's Driverless Deployment service”
California Public Utilities Commission · May 19, 2025
Not found in our sources yet: what has launched; what independent tests found; tested with real people; how many people use it.
Track record and tools.
Failures and court cases are shown beside the stage, never folded into it. Tools are listed because the evidence names them, in no order of merit.
Can AI do these yet?
Answer my health questions
Stage 4 of 6Tested with real people
Randomized trial: chatbot users made no better health decisions
Spot breast cancer on a mammogram
Stage 5 of 6Regulator-cleared
Transpara has been FDA-cleared since 2018, most recently in Aug 2026
Check a mole for skin cancer
Stage 5 of 6Regulator-cleared
EU Class III CE mark lets DERM clear benign cases alone (company)